Medical Director, EMEA Partner Markets- Fixed Term Contract
Share
Job Location:
Basel - Switzerland
Monthly Salary:
Not Disclosed
Posted on:
7 hours ago
Vacancies:
1 Vacancy
Job Summary
Position Summary:
As the Medical Director for the EMEA Partner Markets Cluster you are responsible for overseeing and supporting Medical Affairs activities in Markets in which Ultragenyx commercialize its products in collaboration with 3rd party Distributor Partners. This covers regions such as CEE and MENA. The role includes supporting distributor partners medical activities ensuring alignment with Ultragenyxs strategy providing Medical Affairs training for partners both medical and commercial roles and having oversight over the performance of field activities.
In addition within the 3rd party Distributor Partners region you are responsible for mapping developing and nurturing professional relationships including scientific exchange in a fair-balanced manner with Medical experts and scientific societies in the disease areas related to Ultragenyxs commercialized and late-stage development products not assigned to any 3rd party Distributor Partners.
ultrainnovative Tackle rare and dynamic challenges
Work Model:
Flex: This role will typically require onsite work 2-3 days each week or more depending on business many locations the business will set certain days each week that Flex employees are required to be onsite.
Or
Remote: Officially documented as working full-time from home with travel to Ultragenyxs offices or other locations on occasion as needed.
Responsibilities:
- Serves as the primary medical liaison and medical expert on the relevant therapeutic areas to 3rd party Distributor Partners providing support and guidance on medical affairs strategy and to the extent possible execution
- Oversees and aligns 3rd party Distributor Partner medical activities with Ultragenyxs Global and Regional medical affairs strategy objectives and standards.
- Delivers Medical Affairs training to 3rd party Distributor Partners medical and commercial teams enhancing their understanding of Ultragenyxs products disease areas and Global and Regional medical strategic objectives.
- Monitors and evaluates the performance and outcomes of 3rd party Distributor Partners medical activities to ensure optimal strategy planning and execution vs. the 3rd party Distributor Partners annual medical plan as presented to Ultragenyx.
- Builds and maintains professional relationships with key medical experts and societies and healthcare professionals in the disease areas relevant to Ultragenyxs portfolio.
- Supports the development of the strategy and the introduction of Ultragenyxs pipeline products through market understanding and pre-launch medical activities
- Conducts field visits to compliantly engage with key stakeholders and provide scientific support for educational initiatives advisory boards and symposiums.
- Works closely with Ultragenyx Regional Medical Affairs teams and product Medical leads to align on medical strategy gather product and disease-specific insights and support Ultragenyxs EMEA regional medical initiatives.
- Acts as a promoter of compliance with applicable laws and regulations as well as industry-accepted ethical practices governing interactions with HCPs HCOs patients PAGs payors and other relevant stakeholders vis-à-vis third-party Distribution Partners.
Requirements:
- Advanced degree in clinical specialty (MD PhD PharmD).
- 10 years of experience in Medical Affairs within the pharmaceutical or biotechnology industry with proven field experience.
- Rare Diseases experience particularly in metabolic/genetic disorders. Experience in bone related disease or neurology area is a plus.
- Experience working with distributors or in Partner Market settings. Experience in the GCC preferred.
- Demonstrates the ability to develop good and credible relationships with medical professionals
- Strong leadership and interpersonal skills with the ability to manage relationships across cultures and geographies.
- Excellent communication and presentation skills with fluency in English. Arabic language skills are considered an asset and may be prioritized in the selection process.
- Proven understanding and knowledge of industry-accepted ethical practices applicable to the pharmaceutical industry.
- Adaptability to dynamic environments and diverse market conditions.
- Proactively and consistently delivers on commitments prioritizes time actions and resources to meet goals.
Travel: 50% as Business requires
Location: Switzerland UK Netherlands Austria
Full compliance with Ultragenyx policies industry regulations and applicable laws is required.
#LI-CK1 #LI-Hybrid #LI-Remote
Ultragenyx Pharmaceutical is an equal opportunity employer and prohibits unlawful discrimination based on race color religion gender sexual orientation gender identity/expression national origin/ancestry age disability marital and veteran status and any other status or classification protected by applicable federal state and/or local laws. Reasonable accommodation will be provided for all protected statuses or classifications protected by applicable law including individuals with disabilities disabled veterans for pregnancy childbirth and related medical conditions and based on sincerely held religious beliefs. Applicants can request an accommodation prior to accepting a job offer. If you require reasonable accommodation in completing this application or in any part of the recruitment process you may contact Talent Acquisition by emailing us at .
It is unlawful in Massachusetts to require or administer a lie detector test as a condition of employment or continued employment. An employer who violates this law shall be subject to criminal penalties and civil liability.
Required Experience:
Director
Key Skills
- EMR Systems
- Post Residency Experience
- Occupational Health Experience
- Clinical Research
- Managed Care
- Primary Care Experience
- Medical Management
- Utilization Management
- Clinical Development
- Clinical Trials
- Leadership Experience
- Medicare
About Company
Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward.
